Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019-Reference-Cited by-同舟云学术

Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019

Published:2019-03-11 Issue:3 Volume:17 Page:202-210
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Tempero Margaret A.¹,Malafa Mokenge P.²,Chiorean E. Gabriela³,Czito Brian⁴,Scaife Courtney⁵,Narang Amol K.⁶,Fountzilas Christos⁷,Wolpin Brian M.⁸,Al-Hawary Mahmoud⁹,Asbun Horacio¹⁰,Behrman Stephen W.¹¹,Benson Al B.¹²,Binder Ellen¹³,Cardin Dana B.¹⁴,Cha Charles¹⁵,Chung Vincent¹⁶,Dillhoff Mary¹⁷,Dotan Efrat¹⁸,Ferrone Cristina R.¹⁹,Fisher George²⁰,Hardacre Jeffrey²¹,Hawkins William G.¹³,Ko Andrew H.¹,LoConte Noelle²²,Lowy Andrew M.²³,Moravek Cassadie²⁴,Nakakura Eric K.¹,O’Reilly Eileen M.²⁵,Obando Jorge⁴,Reddy Sushanth²⁶,Thayer Sarah²⁷,Wolff Robert A.²⁸,Burns Jennifer L.²⁹,Zuccarino-Catania Griselda²⁹

Affiliation:

1. 1UCSF Helen Diller Family Comprehensive Cancer Center;

2. 2Moffitt Cancer Center;

3. 3Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

4. 4Duke Cancer Institute;

5. 5Huntsman Cancer Institute at the University of Utah;

6. 6The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

7. 7Roswell Park Comprehensive Cancer Center;

8. 8Dana-Farber/Brigham and Women’s Cancer Center;

9. 9University of Michigan Rogel Cancer Center;

10. 10Mayo Clinic Cancer Center;

11. 11St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center;

12. 12Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

13. 13Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

14. 14Vanderbilt-Ingram Cancer Center;

15. 15Yale Cancer Center/Smilow Cancer Hospital;

16. 16City of Hope National Medical Center;

17. 17The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

18. 18Fox Chase Cancer Center;

19. 19Massachusetts General Hospital Cancer Center;

20. 20Stanford Cancer Institute;

21. 21Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

22. 22University of Wisconsin Carbone Cancer Center;

23. 23UC San Diego Moores Cancer Center;

24. 24Pancreatic Cancer Action Network;

25. 25Memorial Sloan Kettering Cancer Center;

26. 26University of Alabama at Birmingham Comprehensive Cancer Center;

27. 27Fred & Pamela Buffett Cancer Center;

28. 28The University of Texas MD Anderson Cancer Center; and

29. 29National Comprehensive Cancer Network.

Abstract

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of pancreatic adenocarcinoma in relation to survival in the U.S. Military Health System;Cancer Epidemiology;2024-02

2. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer;Cancer Drug Resistance;2024-01-31

3. Predicting Pathological Response to Preoperative Chemotherapy in Pancreatic Ductal Adenocarcinoma Using Post-Chemotherapy Computed Tomography Radiomics;Cureus;2024-01-13

4. Clinical practice guidelines for interventional treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

5. The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries;Surgery;2023-12